Monitoring device safety in interventional cardiology

被引:17
作者
Matheny, ME
Ohno-Machado, L
Resnic, FS
机构
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Radiol, Decis Syst Grp, Boston, MA 02115 USA
[3] Harvard Univ, MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA
关键词
D O I
10.1197/jamia.M1908
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
Objective: A variety of postmarketing surveillance strategies to monitor the safety of medical devices have been supported by the U.S. Food and Drug Administration, but there are few systems to automate surveillance. Our objective was to develop a system to perform real-time monitoring of safety data using a variety of process control techniques. Design: The Web-based Data Extraction and Longitudinal Time Analysis (DELTA) system imports clinical data in real-time from an electronic database and generates alerts for potentially unsafe devices or procedures. The statistical techniques used are statistical process control (SPC), logistic regression (LR), and Bayesian updating statistics (BUS). Measurements: We selected in-patient mortality following implantation of the Cypher drug-eluting coronary stent to evaluate our system. Data from the University of Michigan Consortium Bare-Metal Stent Study was used to calculate the event rate alerting boundaries. Data analysis was performed on local catheterization data from Brigham and Women's Hospital from July 1, 2003, shortly after the Cypher release, to December 31, 2004, including 2,270 cases with 27 observed deaths. Results: The single-stratum SPC had alerts in months 4 and 10. The multistrata SPC had alerts in months 5, 10, and 18 in the moderate-risk stratum, and months 1, 4, 7, and 10 in the high-risk stratum. The only cumulative alerts were in the first month for the high-risk stratum of the multistrata SPC. The LR method showed no monthly or cumulative alerts. The BUS method showed an alert in the first month for the high-risk stratum. Conclusion: The system performed adequately within the Brigham and Women's Hospital Intranet environment based on the design goals. All three cumulative methods agreed that the overall observed event rates were not significantly higher for the new medical device than for a closely related medical device and were consistent with the observation that the initial concerns about this device dissipated as more data accumulated.
引用
收藏
页码:180 / 187
页数:8
相关论文
共 42 条
[1]  
[Anonymous], 2002, Federal Register
[2]  
Bayes T., 1763, Philosophical Transactions, V53, P370, DOI [10.1098/rstl.1763.0053, DOI 10.1098/RSTL.1763.0053]
[3]  
Brown S L, 1997, J Intraven Nurs, V20, P41
[4]   An association of silicone-gel breast implant rupture and fibromyalgia. [J].
Brown S.L. ;
Duggirala H.J. ;
Pennello G. .
Current Rheumatology Reports, 2002, 4 (4) :293-298
[5]   American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes - A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee) [J].
Cannon, CP ;
Battler, A ;
Brindis, RG ;
Cox, JL ;
Ellis, SG ;
Every, NR ;
Flaherty, JT ;
Harrington, RA ;
Krumholz, HM ;
Simoons, ML ;
Van de Werf, FJJ ;
Weintraub, WS ;
Mitchell, KR ;
Morrisson, SL ;
Brandis, RG ;
Anderson, HV ;
Cannom, DS ;
Chitwood, WR ;
Cigarroa, JE ;
Collins-Nakai, RL ;
Ellis, SG ;
Gibbons, RJ ;
Grover, FL ;
Heidenreich, PA ;
Khandheria, BK ;
Knoebel, SB ;
Krumholz, HL ;
Malenka, DJ ;
Mark, DB ;
McKay, CR ;
Passamani, ER ;
Radford, MJ ;
Riner, RN ;
Schwartz, JB ;
Shaw, RE ;
Shemin, RJ ;
Van Fossen, DB ;
Verrier, ED ;
Watkins, MW ;
Phoubandith, DR ;
Furnelli, T .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (07) :2114-2130
[6]  
COOK DF, 1992, FOREST PROD J, V42, P47
[7]  
*CTR DEV RAD HLTH, 2001, ANN REP FISC YEAR 20
[8]  
*DEP HLTH HUM SERV, 1997, IMPR PAT CAR REP FDA
[9]  
Dillard Sharon F, 2002, AORN J, V76, P88, DOI 10.1016/S0001-2092(06)61098-3
[10]  
Doble M., 2005, International Journal of Six Sigma and Competitive Advantage, V1, P229, DOI 10.1504/IJSSCA.2005.006425